ADALAT

This brand name is authorized in Austria, Brazil, Canada, Estonia, Hong Kong SAR China, Ireland, Italy, Japan, Mexico, Netherlands, New Zealand, Nigeria, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug ADALAT contains one active pharmaceutical ingredient (API):

1	Nifedipine UNII I9ZF7L6G2L - NIFEDIPINE
	Nifedipine is a calcium antagonist of the 1,4-dihydropyridine type. Calcium antagonists reduce the transmembranal influx of calcium ions through the slow calcium channel into the cell. As a specific and potent calcium antagonist, nifedipine acts particularly on the cells of the myocardium and the smooth muscle cells of the coronary arteries and the peripheral resistance vessels. The main action of nifedipine is to relax arterial smooth muscle, both in the coronary and peripheral circulation. Nifedipine Tablets are formulated to achieve controlled delivery of nifedipine in a release profile sufficient to enable once-daily administration to be effective in clinical use.
	Read more about Nifedipine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ADALAT Tablet	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C08CA05	Nifedipine	C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	538912060016913, 538912060017113, 538912060017203, 538912060017303, 538912060017513, 538912060017613, 538912060017713
CA	Health Products and Food Branch	02155907
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00047757, 02739175, 02739181, 03344415, 03344421, 03352076, 03352082
EE	Ravimiamet	1006311, 1042456, 1042467, 1072606, 1072617, 1072640, 1154517, 1784112, 1809705
ES	Centro de información online de medicamentos de la AEMPS	56920, 59538
GB	Medicines & Healthcare Products Regulatory Agency	28816
HK	Department of Health Drug Office	37008
IE	Health Products Regulatory Authority	10773, 56031, 56335, 56336, 56337, 56393, 56395
IT	Agenzia del Farmaco	027980010, 027980022, 039782026, 043514013, 043514025, 043515016, 044052013
JP	医薬品医療機器総合機構	2171014G3022, 2171014G4029, 2171014G5025
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	86126
NG	Registered Drug Product Database	A4-2374
Switch country to Nigeria in order to find specific presentations of ADALAT
NL	Z-Index G-Standaard, PRK	33693, 33707
NZ	Medicines and Medical Devices Safety Authority	2888, 2889, 2890
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W63872001, W63872002
SG	Health Sciences Authority	07710P, 08913P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699546031870, 8699546032501
ZA	Health Products Regulatory Authority	27/7.1/0294, A39/7.1/0634, S/7.1/393, Y/7.1/314, Y/7.1/315